Close Menu

Valerie Palmieri, James LaFrance

Vermillion has named Valerie Palmieri president and CEO effective Jan. 1. Current CEO James LaFrance will continue to serve as chairman of the company's board.

Palmieri is currently Vermillion's COO. Prior to joining the company in October, she was president of Momentum Consulting and served as a strategic advisor to the company. Before that she was national vice president of anatomic pathology operations at Laboratory Corporation of America.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.